“We can now roll out virtual lab infrastructure to hundreds of more engineers as well as our training and support teams, and manage it from a central location which allows us to minimize consumption of server, storage and network resources.”Īs today’s business applications are getting increasingly complex, service oriented architectures, firewalls, load balancing networks and clustered applications must be simulated and thoroughly tested in the lab. supplier of healthcare information technology solutions.
"The new organization capabilities in VMware Lab Manager 3 will help us better enforce role-based access rights to system configurations in the lab according to our IT policy,” says Tony Anastasio, technology architect for Cerner, the leading U.S. Because VMware Lab Manager also integrates with Microsoft Active Directory, both user management and resource administration can be centralized to further simplify lab administration and reduce overall resource consumption. IT administrators can set up customized user roles and access rights to dedicated or shared resource pools imported from VMware VirtualCenter to provide users with the highest quality of service. VMware Lab Manager 3 supports multiple organizations of lab users with a single installation, whether users are local or distributed globally. IT administrators need to ensure consistent quality of service and access to appropriate lab resources based on a user’s role in the organization.
LABMANAGER 3 NG SOFTWARE
For example, many organizations wish to establish global lab operations that encompass not only software development and test teams, but also helpdesk operations, training organizations and sales teams that use the lab to recreate customer environments, provide hands-on labs or drive sales demos. With this new release, VMware Lab Manager now offers comprehensive support for multiple organizational units, advanced networking capabilities, and tighter integration with VMware Infrastructure.Īs market adoption of virtual lab automation has grown, so has the need to support an increasingly diverse set of users. VMware Lab Manager has fast become the industry-standard lab automation solution that provides software development and QA engineers with fast and simple self-service provisioning of multi-VM environments while giving IT departments increased control over policies. (NYSE: VMW), the global leader in virtualization solutions from the desktop to the datacenter, today announced the general availability of VMware Lab Manager 3, providing even greater automation and control for IT lab environments.
A QA manager and a QA specialist supervise the GMP aspects of our program.New Release of VMware Lab Manager Enables Multiple Teams and Projects to Effectively Share a Single Global Virtual Lab VMware Lab Manager 3 Offers Support for Multiple Organizations, Advanced Networking Capabilities and Tighter Integration with VMware Infrastructure Institutionally supported staff members include medical physicists who support the clinic and cyclotron facility, 4 radiochemists involved in routine production of radiotracers, a clinical research manager and multiple technologists. My research group currently includes 5 graduate students, 3 coop students, 5 post-doctoral fellows/research associates, 1 research radiochemist, 3 technicians, with 2 nuclear medicine technologists for preclinical imaging. My team consists of scientists, technologists and trainees from a diverse background ranging from molecular biologists, chemists, radiochemists, medical physicists, nuclear medicine technologists to cyclotron operators. I am also leading clinical trials using 18F- and 177Lu-labeled radiopharmaceuticals for diagnosis and therapy of prostate cancer. As part of this network, I led multicenter prospective clinical trials on the use of 18F-NaF to detect bone metastases in breast and prostate cancers and on the clinical validation of cyclotron produced 99mTc.
LABMANAGER 3 NG TRIAL
I managed the PET/CT core laboratory for the Medical Imaging Trial Network of Canada. I have extensive experience directing PET programs and a cyclotron facility and have always been intimately involved in the operation of the cyclotron and radiochemistry laboratories. We established a state-of-the art cyclotron and molecular imaging facility at BC Cancer.
I bridge the gap between basic science and clinical applications. My expertise covers both pre-clinical research related to the evaluation of novel radiopharmaceuticals, from the design phase to receptor-binding assays, preclinical evaluation, and clinical research ranging from phase 0-1 studies to multicentre clinical trials. I am a clinician-scientist and the BC Leadership Chair in Functional Cancer Imaging with a primary interest in developing new molecular imaging tools and methods for the diagnosis and in vivo characterization of cancers.
0 kommentar(er)
